Peripheral endothelial dysfunction in patients suffering from acute schizophrenia: A potential marker for cardiovascular morbidity?

Schizophrenia Research

Volumn 128, Issue 1-3, 2011, Pages 44-50

  Israel, Anna Karoline ^a   Seeck, Andrea ^b   Boettger, Michael Karl ^a   Rachow, Tobias ^a   Berger, Sandy ^a   Voss, Andreas ^b   Bär, Karl Jürgen ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

Author keywords

Cardiac mortality; Cardiac risk; Endothelial function; Post occlusive reactive hyperemia; Vasomotion

Indexed keywords

ADULT; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART RATE; HUMAN; HYPEREMIA; MALE; MORBIDITY; MORTALITY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PULSE PRESSURE; SCHIZOPHRENIA; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD FLOW VELOCITY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; RISK FACTORS; SCHIZOPHRENIA; SKIN; SPECTRUM ANALYSIS; VASCULAR DISEASES; YOUNG ADULT;

EID: 79955478916     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2011.02.007     Document Type: Article

References (62)

1. Anderson T.J., Elstein E., Haber H., Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J. Am. Coll. Cardiol. 2000, 35:60-66.
2. Antonios T.F., Rattray F.E., Singer D.R., Markandu N.D., Mortimer P.S., MacGregor G.A. Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin. Sci. Lond 1999, 97:523-528.
3. Azman-Juvan K., Bernjak A., Urbancic-Rovan V., Stefanovska A., Stajer D. Skin blood flow and its oscillatory components in patients with acute myocardial infarction. J. Vasc. Res. 2008, 45:164-172.
4. Bär K.J., Letzsch A., Jochum T., Wagner G., Greiner W., Sauer H. Loss of efferent vagal activity in acute schizophrenia. J. Psychiatr. Res. 2005, 39:519-527.
5. Bär K.J., Boettger M.K., Voss A. Differences between heart rate and blood pressure variability in schizophrenia. Biomed. Tech. Berl 2006, 51:237-239.
6. Bär K.J., Boettger M.K., Boettger S., Grotelüschen M., Neubauer R., Jochum T., Baier V., Sauer H., Voss A. Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome and in abstained alcoholics. Drug Alcohol Depend. 2006, 85:66-74.
7. Bär K.J., Koschke M., Boettger M.K., Berger S., Kabisch A., Sauer H., Voss A., Yeragani V.K. Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophr. Res. 2007, 95:115-123.
8. Bär K.J., Boettger M.K., Berger S., Baier V., Sauer H., Yeragani V.K., Voss A. Decreased baroreflex sensitivity in acute schizophrenia. J. Appl. Physiol. 2007, 102:1051-1056.
9. Bär K.J., Boettger M.K., Schulz S., Harzendorf C., Agelink M.W., Yeragani V.K., Chokka P., Voss A. The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin. Neurophysiol. 2008, 119:2209-2213.
10. Bär K.J., Wernich K., Boettger S., Cordes J., Boettger M.K., Loffler S., Kornischka J., Agelink M.W. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res. 2008, 157:255-257.
11. Bär K.J., Berger S., Metzner M., Boettger M.K., Schulz S., Ramachandraiah C.T., Terhaar J., Voss A., Yeragani V.K., Sauer H. Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia. Schizophr. Bull. 2010, 36:1050-1058.
12. Bardenheuer H.J., Fabry A., Hofling B., Peter K. Adenosine: a sensitive marker of myocardial ischaemia in man. Cardiovasc. Res. 1994, 28:656-662.
13. Berger S., Boettger M.K., Tancer M., Guinjoan S.M., Yeragani V.K., Bär K.J. Reduced cardio-respiratory coupling indicates suppression of vagal activity in healthy relatives of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:406-411.
14. Bircher A., de Boer E.M., Agner T., Wahlberg J.E., Serup J. Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermat. 1994, 30:65-72.
15. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., Rejas J. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study. Eur. Psychiatry. 2010, doi:10.1016/j.eurpsy.2010.09.001.
16. Boettger S., Hoyer D., Falkenhahn K., Kaatz M., Yeragani V.K., Bär K.J. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin. Neurophysiol. 2006, 117:2715-2722.
17. Boke O., Aker S., Sarisoy G., Saricicek E.B., Sahin A.R. Prevalence of metabolic syndrome among inpatients with schizophrenia. Int. J. Psychiatry Med. 2008, 38:103-112.
18. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23:168-175.
19. Bracic M., Stefanovska A. Wavelet-based analysis of human blood-flow dynamics. Bull. Math. Biol. 1998, 60:919-935.
20. Colantuoni A., Bertuglia S., Intaglietta M. Quantitation of rhythmic diameter changes in arterial microcirculation. Am. J. Physiol. 1984, 246:H508-H517.
21. Colantuoni A., Bertuglia S., Intaglietta M. Microvascular vasomotion: origin of laser Doppler flux motion. Int. J. Microcirc. Clin. Exp. 1994, 14:151-158.
22. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., Vallance P., Vita J., Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002, 39:257-265.
23. Curkendall S.M., Mo J., Glasser D.B., Rose Stang M., Jones J.K. Cardiovascular disease in patients with schizophrenia in Saskatchewan. Canada. J. Clin. Psychiatry 2004, 65:715-720.
24. de Jongh R.T., Serne E.H., IJzerman R.G., Jorstad H.T., Stehouwer C.D. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc. Res. 2008, 75:256-262.
25. First M.B. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinical Version 1997, American Psychiatric Publishing, Arlington, VA, USA. G.M.W.J.B.W. Spitzer Rl (Ed.).
26. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80:45-53.
27. Gustafsson H. Vasomotion and underlying mechanisms in small arteries. An in vitro study of rat blood vessels. Acta Physiol. Scand. Suppl. 1993, 614:1-44.
28. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150:1115-1121.
29. Hoffmann U., Franzeck U.K., Geiger M., Yanar A., Bollinger A. Variability of different patterns of skin oscillatory flux in healthy controls and patients with peripheral arterial occlusive disease. Int. J. Microcirc. Clin. Exp. 1993, 12:255-273.
30. Intaglietta M., Mirhashemi S., Tompkins W.R. Capillary fluxmeter: the simultaneous measurement of hematocrit, velocity and flux. Int. J. Microcirc. Clin. Exp. 1989, 8:313-320.
31. Joannides R., Haefeli W.E., Linder L., Richard V., Bakkali E.H., Thuillez C., Luscher T.F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-1319.
32. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
33. Koponen H., Alaraisanen A., Saari K., Pelkonen O., Huikuri H., Raatikainen M.J., Savolainen M., Isohanni M. Schizophrenia and sudden cardiac death: a review. Nord. J. Psychiatry 2008, 62:342-345.
34. Koschke M., Boettger M.K., Schulz S., Berger S., Terhaar J., Voss A., Yeragani V.K., Bär K.J. Autonomy of autonomic dysfunction in major depression. Psychosom. Med. 2009, 71:852-860.
35. Kvandal P., Stefanovska A., Veber M., Kvernmo H.D., Kirkeboen K.A. Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandins. Microvasc. Res. 2003, 65:160-171.
36. Kvernmo H.D., Stefanovska A., Kirkeboen K.A., Kvernebo K. Oscillations in the human cutaneous blood perfusion signal modified by endothelium-dependent and endothelium-independent vasodilators. Microvasc. Res. 1999, 57:298-309.
37. Lerman A., Zeiher A.M. Endothelial function: cardiac events. Circulation 2005, 111:363-368.
38. Lorenzo S., Minson C.T. Human cutaneous reactive hyperaemia: role of BKCa channels and sensory nerves. J. Physiol. 2007, 585:295-303.
39. Loscalzo J., Vita J.A. Ischemia, hyperemia, exercise, and nitric oxide. Complex physiology and complex molecular adaptations. Circulation 1994, 90:2556-2559.
40. Meyer H.J., Terrahe K., Haug H., Schmidt W. Free small intestine transplantation in plastic reconstruction of the oral cavity, pharynx and cervical esophagus. Report of experiences following 3 years of use. Laryngol. Rhinol. Otol. (Stuttg) 1988, 67:1-6.
41. Muck-Weymann M.E., Albrecht H.P., Hager D., Hiller D., Hornstein O.P., Bauer R.D. Respiratory-dependent laser-Doppler flux motion in different skin areas and its meaning to autonomic nervous control of the vessels of the skin. Microvasc. Res. 1996, 52:69-78.
42. O'Leary D.S. Regional vascular resistance vs. conductance: which index for baroreflex responses?. Am. J. Physiol. 1991, 260:H632-H637.
43. Peng H., Matchkov V., Ivarsen A., Aalkjaer C., Nilsson H. Hypothesis for the initiation of vasomotion. Circ. Res. 2001, 88:810-815.
44. Peupelmann J., Boettger M.K., Ruhland C., Berger S., Ramachandraiah C.T., Yeragani V.K., Bär K.J. Cardio-respiratory coupling indicates suppression of vagal activity in acute schizophrenia. Schizophr. Res. 2009, 112:153-157.
45. Prazny M., Jezkova J., Horova E., Lazarova V., Hana V., Kvasnicka J., Pecen L., Marek J., Skrha J., Krsek M. Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension. Physiol. Res. 2008, 57:13-22.
46. Ray W.A., Chung C.P., Murray K.T., Hall K., Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 2009, 360:225-235.
47. Rizzoni D., Porteri E., De Ciuceis C., Sleiman I., Rodella L., Rezzani R., Paiardi S., Bianchi R., Ruggeri G., Boari G.E., Muiesan M.L., Salvetti M., Zani F., Miclini M., Rosei E.A. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension 2005, 45:659-665.
48. Rossi M., Bertuglia S., Varanini M., Giusti A., Santoro G., Carpi A. Generalised wavelet analysis of cutaneous flowmotion during post-occlusive reactive hyperaemia in patients with peripheral arterial obstructive disease. Biomed. Pharmacother. 2005, 59:233-239.
49. Rossi M., Carpi A., Di Maria C., Galetta F., Santoro G. Spectral analysis of laser Doppler skin blood flow oscillations in human essential arterial hypertension. Microvasc. Res. 2006, 72:34-41.
50. Rossi M., Carpi A., Galetta F., Franzoni F., Santoro G. The investigation of skin blood flowmotion: a new approach to study the microcirculatory impairment in vascular diseases?. Biomed. Pharmacother. 2006, 60:437-442.
51. Rossi M., Carpi A., Di Maria C., Galetta F., Santoro G. Absent post-ischemic increase of blood flowmotion in the cutaneous microcirculation of healthy chronic cigarette smokers. Clin. Hemorheol. Microcirc. 2007, 36:163-171.
52. Rossi M., Carpi A., Galetta F., Franzoni F., Santoro G. Skin vasomotion investigation: a useful tool for clinical evaluation of microvascular endothelial function?. Biomed. Pharmacother. 2008, 62:541-545.
53. Rousseau P., Mahe G., Fromy B., Ducluzeau P.H., Saumet J.L., Abraham P. Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin. Microvasc. Res. 2009, 78:218-223.
54. Rudolph T.K., Ruempler K., Schwedhelm E., Tan-Andresen J., Riederer U., Böger R.H., Maas R. Acute effects of various fast-food meals on vascular function and cardiovascular disease risk markers: the Hamburg Burger Trial. Am. J. Clin. Nutr. 2007, 86:334-340.
55. Schmiedel O., Schroeter M.L., Harvey J.N. Microalbuminuria in Type 2 diabetes indicates impaired microvascular vasomotion and perfusion. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3424-H3431.
56. Serne E.H., Ijzerman R.G., de Jongh R.T., Stehouwer C.D. Blood pressure and insulin resistance: role for microvascular function?. Cardiovasc. Res. 2002, 55:418-419.
57. Shechter M., Matetzky S., Arad M., Feinberg M.S., Freimark D. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur. J. Heart Fail. 2009, 11:588-593.
58. Stefanovska A., Bracic M., Kvernmo H.D. Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique. IEEE Trans. Biomed. Eng. 1999, 46:1230-1239.
59. Stewart J., Kohen A., Brouder D., Rahim F., Adler S., Garrick R., Goligorsky M.S. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2687-H2696.
60. Tagawa T., Imaizumi T., Endo T., Shiramoto M., Harasawa Y., Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994, 90:2285-2290.
61. Verma S., Anderson T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002, 105:546-549.
62. Vuilleumier P., Decosterd D., Maillard M., Burnier M., Hayoz D. Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J. Hypertens. 2002, 20:1753-1757.